Lewis H. Bender to Discuss Factors of Inflammation in Chronic Diseases of
WALTHAM, Mass., June 10 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Lewis H. Bender, Chief Executive Officer, will make a corporate presentation at the BIO Business Forum during the 2008 BIO International Convention in San Diego, CA. The presentation will be held on Wednesday, June 18 at 1:30 PM PDT in room 5A. The presentation will not be webcast. Mr. Bender will be available for one-on-one meetings throughout the conference. For more information, please visit http://www.bio2008.org .
WHO: Lewis H. Bender, Chief Executive Officer of Interleukin Genetics
WHERE: BIO International Convention, San Diego Convention Center, San Diego, CA
WHEN: Wednesday, June 18 at 1:30 PM PDT
WHAT: Long before anyone was using the words "personalized healthcare" and "personalized medicine," Interleukin Genetics was focused on harnessing knowledge about the genetics of a key bodily defense system - inflammation - and developing ways to modulate that system that would promote wellness. Interleukin Genetics will use the BIO Business Forum to discuss the company's proprietary intellectual property, partnering, business model, commercialized genetic tests, and recent milestones.
About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused
personalized health company
|SOURCE Interleukin Genetics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved